These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12373662)

  • 1. [Characteristics and indications of oxcarbazepine].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S101-9. PubMed ID: 12373662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Oxcarbazepine in the treatment of epilepsy. A review and update].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Jan 16-31; 42(2):95-113. PubMed ID: 16450324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxcarbazepine.
    Tecoma ES
    Epilepsia; 1999; 40 Suppl 5():S37-46. PubMed ID: 10530693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?
    Schmidt D; Elger CE
    Epilepsy Behav; 2004 Oct; 5(5):627-35. PubMed ID: 15380112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Oxcarbazepine].
    Arroyo S
    Neurologia; 2001 Oct; 16(8):370-5. PubMed ID: 11738014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of oxcarbazepine and carbamazepine: a double-blind study.
    Reinikainen KJ; Keränen T; Halonen T; Komulainen H; Riekkinen PJ
    Epilepsy Res; 1987 Sep; 1(5):284-9. PubMed ID: 3504404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients.
    McKee PJ; Blacklaw J; Forrest G; Gillham RA; Walker SM; Connelly D; Brodie MJ
    Br J Clin Pharmacol; 1994 Jan; 37(1):27-32. PubMed ID: 8148215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial.
    Beydoun A; Sachdeo RC; Rosenfeld WE; Krauss GL; Sessler N; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2245-51. PubMed ID: 10881247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oxcarbazepine in the treatment of epilepsy].
    Freidel M; Krause E; Kuhn K; Peper R; Vogel H
    Fortschr Neurol Psychiatr; 2007 Feb; 75(2):100-6. PubMed ID: 17200915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.
    Koch MW; Polman SK
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006453. PubMed ID: 19821367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
    Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
    Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy.
    Barcs G; Walker EB; Elger CE; Scaramelli A; Stefan H; Sturm Y; Moore A; Flesch G; Kramer L; D'Souza J
    Epilepsia; 2000 Dec; 41(12):1597-607. PubMed ID: 11114219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine.
    Albani F; Baruzzi A;
    Neurol Sci; 2006 Jul; 27(3):173-5. PubMed ID: 16897629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxcarbazepine: a review of its use in children with epilepsy.
    Bang L; Goa K
    Paediatr Drugs; 2003; 5(8):557-73. PubMed ID: 12895138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical recommendations for oxcarbazepine.
    Smith PE;
    Seizure; 2001 Mar; 10(2):87-91. PubMed ID: 11421225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.
    Löfgren E; Tapanainen JS; Koivunen R; Pakarinen A; Isojärvi JI
    Epilepsia; 2006 Sep; 47(9):1441-6. PubMed ID: 16981858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication.
    Vainionpää LK; Mikkonen K; Rättyä J; Knip M; Pakarinen AJ; Myllylä VV; Isojärvi JI
    Epilepsia; 2004 Mar; 45(3):197-203. PubMed ID: 15009219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.